293 listed companies, 6 industries.
| Industry | Companies | Market cap | Median P/E | Median ROE | Median 1y return |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 195 | ₹18,99,995 Cr | 37.8 | 9.8% | — |
| Pharmaceuticals | 3 | ₹6,41,786 Cr | 32.3 | 11.8% | — |
| Healthcare Services | 75 | ₹5,92,300 Cr | 55.3 | 10.9% | — |
| API Manufacturing | 1 | ₹2,45,561 Cr | 84.0 | 16.2% | — |
| Company | Industry | Market cap | P/E | ROE | Profit growth 1y | 1y return |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals LimitedTORNTPHARM | Pharmaceuticals & Biotechnology | ₹1,61,325 Cr | 74.0 | 27.1% | +13.2% | — |
| Hospitals | 1 | ₹1,16,960 Cr | 56.0 | 21.9% | — |
| Healthcare Equipment & Supplies | 18 | ₹41,900 Cr | 40.1 | 11.9% | — |
| Pharmaceuticals & Biotechnology |
| ₹1,14,284 Cr |
| 25.3 |
| 19.7% |
| +3,326.2% |
| — |
| Laurus Labs LimitedLAURUSLABS | Pharmaceuticals & Biotechnology | ₹1,07,176 Cr | 98.0 | 18.2% | +148% | — |
| Mankind Pharma LimitedMANKIND | Pharmaceuticals & Biotechnology | ₹1,04,696 Cr | 50.6 | 12.5% | -3.7% | — |
| Aurobindo Pharma LimitedAUROPHARMA | Pharmaceuticals & Biotechnology | ₹97,389 Cr | 26.2 | 9.9% | +0.5% | — |
| Lupin LimitedLUPIN | Pharmaceuticals & Biotechnology | ₹92,866 Cr | 16.8 | 26.9% | +62.5% | — |
| Glenmark Pharmaceuticals LimitedGLENMARK | Pharmaceuticals & Biotechnology | ₹65,781 Cr | 44.0 | 0.0% | -100% | — |
| Alkem Laboratories LimitedALKEM | Pharmaceuticals & Biotechnology | ₹62,431 Cr | 28.9 | 17.8% | +6.3% | — |
| Biocon LimitedBIOCON | Pharmaceuticals & Biotechnology | ₹60,413 Cr | 122.0 | 1.4% | -61.9% | — |
| Abbott India LimitedABBOTINDIA | Pharmaceuticals & Biotechnology | ₹56,901 Cr | 82.4 | 34.5% | +9.7% | — |
| Ipca Laboratories LimitedIPCALAB | Pharmaceuticals & Biotechnology | ₹49,299 Cr | 37.6 | 15.2% | +54.7% | — |
| Anthem Biosciences LimitedANTHEM | Pharmaceuticals & Biotechnology | ₹48,213 Cr | 83.7 | 19.5% | — | — |
| Gland Pharma LimitedGLAND | Pharmaceuticals & Biotechnology | ₹47,428 Cr | 42.0 | 10.5% | +47.1% | — |
| Glaxosmithkline Pharmaceuticals LimitedGLAXO | Pharmaceuticals & Biotechnology | ₹46,942 Cr | 43.9 | 49.1% | +11.7% | — |
| Ajanta Pharma LimitedAJANTPHARM | Pharmaceuticals & Biotechnology | ₹44,727 Cr | 39.6 | 25.4% | +14.7% | — |
| Jb Chemicals & Pharmaceuticals LimitedJBCHEPHARM | Pharmaceuticals & Biotechnology | ₹38,741 Cr | 54.3 | 18.7% | +8,207.6% | — |
| Emcure Pharmaceuticals LimitedEMCURE | Pharmaceuticals & Biotechnology | ₹36,889 Cr | 36.5 | 19.7% | +35.7% | — |
| Wockhardt LimitedWOCKPHARMA | Pharmaceuticals & Biotechnology | ₹33,863 Cr | 82.8 | 4.6% | — | — |
| Sai Life Sciences LimitedSAILIFE | Pharmaceuticals & Biotechnology | ₹32,720 Cr | 90.4 | 15.1% | +105.1% | — |
| Neuland Laboratories LimitedNEULANDLAB | Pharmaceuticals & Biotechnology | ₹27,526 Cr | 55.3 | 21.4% | +39.9% | — |
| Rubicon Research LimitedRUBICON | Pharmaceuticals & Biotechnology | ₹26,975 Cr | 93.6 | 19.1% | — | — |
| Piramal Pharma LimitedPPLPHARMA | Pharmaceuticals & Biotechnology | ₹26,356 Cr | — | -4.0% | — | — |
| Acutaas Chemicals LimitedACUTAAS | Pharmaceuticals & Biotechnology | ₹26,179 Cr | 67.8 | 24.0% | +124.5% | — |
| Shilpa Medicare LimitedSHILPAMED | Pharmaceuticals & Biotechnology | ₹20,814 Cr | 70.0 | 9.8% | +210.8% | — |
| Granules India LimitedGRANULES | Pharmaceuticals & Biotechnology | ₹20,363 Cr | 30.7 | 13.5% | +18.6% | — |
| Caplin Point Laboratories LimitedCAPLIPOINT | Pharmaceuticals & Biotechnology | ₹20,002 Cr | 30.1 | 19.9% | +13.8% | — |
| Pfizer LimitedPFIZER | Pharmaceuticals & Biotechnology | ₹17,635 Cr | 24.0 | 17.2% | -5.9% | — |
| Onesource Specialty Pharma LimitedONESOURCE | Pharmaceuticals & Biotechnology | ₹17,282 Cr | — | -1.3% | — | — |
| Cohance Lifesciences LimitedCOHANCE | Pharmaceuticals & Biotechnology | ₹17,267 Cr | 162.5 | 6.4% | -33.1% | — |
| Alivus Life Sciences LimitedALIVUS | Pharmaceuticals & Biotechnology | ₹16,861 Cr | 28.0 | 18.4% | +16.2% | — |
| Eris Lifesciences LimitedERIS | Pharmaceuticals & Biotechnology | ₹16,491 Cr | 25.6 | 18.3% | +76.1% | — |
| Alembic Pharmaceuticals LimitedAPLLTD | Pharmaceuticals & Biotechnology | ₹16,028 Cr | 23.2 | 12.3% | +15% | — |
| Jubilant Pharmova LimitedJUBLPHARMA | Pharmaceuticals & Biotechnology | ₹15,919 Cr | 45.2 | 6.0% | -52.5% | — |
| Astrazeneca Pharma India LimitedASTRAZEN | Pharmaceuticals & Biotechnology | ₹15,078 Cr | 88.9 | 22.8% | +62% | — |
| Marksans Pharma LimitedMARKSANS | Pharmaceuticals & Biotechnology | ₹14,756 Cr | 28.6 | 25.6% | +992.3% | — |
| Natco Pharma LimitedNATCOPHARM | Pharmaceuticals & Biotechnology | ₹14,709 Cr | 12.9 | 16.9% | -24.8% | — |
| Concord Biotech LimitedCONCORDBIO | Pharmaceuticals & Biotechnology | ₹14,373 Cr | 52.2 | 13.6% | -29.8% | — |
| Akums Drugs And Pharmaceuticals LimitedAKUMS | Pharmaceuticals & Biotechnology | ₹12,798 Cr | 43.9 | 8.0% | -24.5% | — |
| Corona Remedies LimitedCORONA | Pharmaceuticals & Biotechnology | ₹12,420 Cr | 62.4 | 32.0% | +118% | — |
| Viyash Scientific LimitedVIYASH | Pharmaceuticals & Biotechnology | ₹10,125 Cr | 59.2 | 9.8% | +710.2% | — |
| Strides Pharma Science LimitedSTAR | Pharmaceuticals & Biotechnology | ₹10,002 Cr | 16.3 | 19.7% | -84.5% | — |
| Blue Jet Healthcare LimitedBLUEJET | Pharmaceuticals & Biotechnology | ₹9,400 Cr | 40.0 | 19.9% | -18.8% | — |
| Procter & Gamble Health LimitedPGHL | Pharmaceuticals & Biotechnology | ₹8,898 Cr | 24.9 | — | +9.2% | — |
| Aarti Pharmalabs LimitedAARTIPHARM | Pharmaceuticals & Biotechnology | ₹8,784 Cr | 41.4 | 8.4% | -36.6% | — |
| Sanofi Consumer Healthcare India LimitedSANOFICONR | Pharmaceuticals & Biotechnology | ₹8,711 Cr | 48.1 | — | +9.8% | — |
| Symbiotec Pharmalab LimitedSYMBIOTEC | Pharmaceuticals & Biotechnology | ₹7,703 Cr | 70.8 | 11.1% | +13.8% | — |
| Supriya Lifescience LimitedSUPRIYA | Pharmaceuticals & Biotechnology | ₹7,495 Cr | 37.8 | 19.1% | +11.3% | — |
| Morepen Laboratories LimitedMOREPENLAB | Pharmaceuticals & Biotechnology | ₹7,328 Cr | 52.1 | 7.9% | -19.6% | — |
| Bliss Gvs Pharma LimitedBLISSGVS | Pharmaceuticals & Biotechnology | ₹7,253 Cr | 53.3 | 11.5% | +53.2% | — |
| Sanofi India LimitedSANOFI | Pharmaceuticals & Biotechnology | ₹6,986 Cr | 16.9 | 44.1% | -31.4% | — |